Avalo Therapeutics
AVTX
AVTX
33 hedge funds and large institutions have $56M invested in Avalo Therapeutics in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $63.2M → $56M (-$7.25M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.76M | |
| 2 | +$1.15M | |
| 3 | +$987K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$872K |
| 5 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$817K |
Top Sellers
| 1 | -$5.12M | |
| 2 | -$743K | |
| 3 | -$743 | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$743 |
| 5 |
Wells Fargo
San Francisco,
California
|
-$10 |